Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Senescence, Frailty, and Mesenchymal Stem Cell Functionality in Chronic Kidney Disease: Effect of Senolytic Agents

NCT02848131 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02848131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02848131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Senescence, Frailty, and Mesenchymal Stem Cell Functionality in Chronic Kidney Disease: Effect of Senolytic Agents
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
July 31, 2016
Completion date
April 30, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease